CVE-2017-5991

Public Exploit

Description

An issue was discovered in Artifex MuPDF before 1912de5f08e90af1d9d0a9791f58ba3afdb9d465. The pdf_run_xobject function in pdf-op-run.c encounters a NULL pointer dereference during a Fitz fz_paint_pixmap_with_mask painting operation. Versions 1.11 and later are unaffected.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 19.34% Top 5%
Vendor Advisory debian.org Vendor Advisory gentoo.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://git.ghostscript.com/?p=mupdf.git%3Bh=1912de5f08e90af1d9d0a9791f58ba3afdb9d465
http://www.debian.org/security/2017/dsa-3797 third party advisory vendor advisory
https://bugs.ghostscript.com/show_bug.cgi?id=697500 third party advisory exploit
https://security.gentoo.org/glsa/201706-08 third party advisory vendor advisory
https://www.exploit-db.com/exploits/42138/ exploit vdb entry third party advisory
http://www.securityfocus.com/bid/96213 vdb entry broken link

Frequently Asked Questions

What is the severity of CVE-2017-5991?
CVE-2017-5991 has been scored as a high severity vulnerability.
How to fix CVE-2017-5991?
To fix CVE-2017-5991, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-5991 being actively exploited in the wild?
It is possible that CVE-2017-5991 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~19% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.